NFE2L2 and ischemic cardiomyopathy: Current studies have shown that activating the expression of Nrf2 and its downstream genes can significantly reduce oxidative stress, inflammation, and myocardial cell apoptosis, and significantly alleviate myocardial remodeling caused by hypertension, diabetes, and ischemic cardiomyopathy [20].